<DOC>
	<DOCNO>NCT00004397</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate effectiveness tin mesoporphyrin reduce number heme infusion need prevent acute attack porphyria . II . Evaluate safety tolerability tin mesoporphyrin patient .</brief_summary>
	<brief_title>Phase I Study Tin Mesoporphyrin Patients Long Term Heme Therapy Prevention Acute Attacks Porphyria</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This unblinded study . Patients start preventive heme regimen follow 6 month prior tin mesoporphyrin . The frequency attack record . Patients receive tin mesoporphyrin week 6 month . Patients must avoid sunlight treatment 2 month thereafter . The frequency heme infusion reduce half frequency attack porphyria monitor . Patients follow 6 month last treatment .</detailed_description>
	<mesh_term>Porphyrias</mesh_term>
	<mesh_term>Porphyria , Erythropoietic</mesh_term>
	<mesh_term>Tin mesoporphyrin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Documented acute intermittent porphyria , variegate porphyria , hereditary coproporphyria cause 6 attack per year Fewer 2 attack precede 6 month already preventive heme therapy Prior/Concurrent Therapy See Disease Characteristics Patient Characteristics Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Urinary porphobilinogen least 20 mg/24 hour acute symptom Other : Not pregnant Fertile female patient must use effective contraception 6 month prior study No recurrent symptom due another illness No continuous ( longer 1 month ) symptoms porphyria unless addition acute exacerbations No acute hemorrhagic disorder : Gastrointestinal bleed Intracerebral hemorrhage No known hypersensitivity tin mesoporphyrin No known hypersensitivity intravenous heme preparation No condition may increase risk patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2000</verification_date>
	<keyword>inborn error metabolism</keyword>
	<keyword>porphyria</keyword>
	<keyword>rare disease</keyword>
</DOC>